Showing results (161-170 of 378) with videos related to
Sort By:
Pageof 38
Annals of Surgery|October 13, 2012
Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: a report from the prospective COST trialKellie L Mathis, Erin M Green, Daniel J Sargent, et al.The Annals of Thoracic Surgery|April 23, 2016
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032)Michael S Kent, Sumithra J Mandrekar, Rodney Landreneau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung CancerRamaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.Cancer|July 30, 2011
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE)Blase N Polite, Amy Sing, Daniel J Sargent, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|March 23, 2023
Genomic selection strategies for clonally propagated cropsChristian R Werner, R Chris Gaynor, Daniel J Sargent, et al.Cancer Chemotherapy and Pharmacology|June 10, 2006
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignanciesCynthia Ma, Sumithra J Mandrekar, Steven R Alberts, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment StudiesJoseph M Unger, Michael LeBlanc, Suzanne George, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2012
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528Grace K Dy, Sumithra J Mandrekar, Garth D Nelson, et al.Plos One|June 8, 2011
An autotetraploid linkage map of rose (Rosa hybrida) validated using the strawberry (Fragaria vesca) genome sequenceOron Gar, Daniel J Sargent, Ching-Jung Tsai, et al.Pageof 38